| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Sphingolipid pathway 0.8895047893368319 2.599669343661642 0.0093313624993174 0.9967775247921724 0.5354181884470994 7 Q13510,Q06136,P04062,O95470 4 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.6605459235485682 2.523297312156703 0.011626006043266 0.999220454326766 0.5354181884470994 23 P48449,Q16850,Q15800,P53602,Q14739,Q15392,O00767,P37268 8 |
| Sphingolipid metabolism overview 0.9150222604039672 2.4114777107215777 0.0158880229526565 0.999944633810166 0.5391528575537634 5 Q13510,Q06136,O95470 3 |
| Sphingolipid metabolism integrated pathway 0.9150222604039672 2.4114777107215777 0.0158880229526565 0.999944633810166 0.5391528575537634 5 Q13510,Q06136,O95470 3 |
| Degradation pathway of sphingolipids including diseases 0.8375286171677979 2.3758292595456876 0.0175095628438817 0.9999798191636186 0.5391528575537634 7 P16278,P15289,P17900,O43681,P06280 5 |
| Cholesterol biosynthesis pathway 0.6932129161371865 2.2868942420128087 0.0222019967950741 0.9999989223508838 0.5391528575537634 12 P48449,Q16850,Q15800,P53602,P37268 5 |
| Mitochondrial complex iii assembly 0.7243320643408317 2.2866352624042134 0.022217121227392 0.9999989325042048 0.5391528575537634 10 Q9UDW1,P14927,Q9BRT2,Q6DKK2 4 |
| Sphingolipid metabolism in senescence 0.6586831195315216 2.1889919493132934 0.0285974251693597 0.9999999805758876 0.5456228423352106 13 P16278,Q13510,Q06136,P04062 4 |
| Glycosaminoglycan degradation 0.8569729065397703 2.177801213334516 0.0294208395376829 0.999999988440238 0.5456228423352106 5 P16278,P15586 2 |
| Oxidation by cytochrome p450 0.8289384655669378 2.062817932144503 0.0391299296478411 0.999999999975409 0.6301978143283886 5 Q16850,O43169 2 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7750690957933687 1.9474588220812248 0.051479751893328 0.999999999999991 0.7203647530001598 6 P09601 1 |
| Progeriaassociated lipodystrophy 0.6445114272251731 1.8705242173743857 0.0614110572346757 1.0 0.7203647530001598 10 O60725,O75844 2 |
| Mitochondrial complex i assembly model oxphos system 0.5645340657214206 1.865630806846765 0.0620930364112912 1.0 0.7203647530001598 24 P51970,O75489,Q9NX14,Q9P032,O96000,Q9Y6M9,Q7L592,Q96CU9,Q9BU61,Q8IUX1,O75380,O75306 12 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7499649713656582 1.838299532045074 0.0660182800333211 1.0 0.7203647530001598 6 Q16850,Q15392,Q14739 3 |
| Eicosanoid metabolism via lipooxygenases lox 0.7497374756979813 1.8373054182891495 0.0661648204715272 1.0 0.7203647530001598 6 Q14914,Q8N8N7 2 |
| Familial partial lipodystrophy fpld 0.7174918542339259 1.8369387844130232 0.0662189328837365 1.0 0.7203647530001598 7 O60725,O75844 2 |
| Nephrotic syndrome 0.5973038989439617 1.8348101908133008 0.0665338181336698 1.0 0.7203647530001598 13 Q14108,O75844 2 |
| Fluoropyrimidine activity 0.6182640557102201 1.796016095547469 0.0724919572309623 1.0 0.7203647530001598 11 P00374,P04818 2 |
| Kennedy pathway from sphingolipids 0.8167458981624207 1.7902361165120624 0.0734159612761731 1.0 0.7203647530001598 4 O95470 1 |
| Mitochondrial immune response to sarscov2 0.6164350638324886 1.785930309191612 0.0741105427629205 1.0 0.7203647530001598 11 Q86UT6,Q9UHD2,Q9Y6M9,Q99623 4 |
| Serine metabolism 0.7023280205386602 1.7668153179379051 0.0772591625234702 1.0 0.7203647530001598 7 P00374 1 |
| Triacylglyceride synthesis 0.8107341745885326 1.7661138977926767 0.0773767423107889 1.0 0.7203647530001598 4 Q9HCL2 1 |
| Metabolism of spingolipids in er and golgi apparatus 0.9435551811288958 1.726105333874816 0.0843284644288617 1.0 0.7203647530001598 3 Q06136,O95470 2 |
| Glycerophospholipid biosynthetic pathway 0.685127108938147 1.6867846325851654 0.0916447714369739 1.0 0.7203647530001598 7 P48651,Q9HCL2 2 |
| Glycosylation and related congenital defects 0.5924312465773688 1.652845704576014 0.0983622696254038 1.0 0.7203647530001598 11 Q9H553,Q9BT22,Q2TAA5,P34949,Q9Y5P6,Q9BV10 6 |
| Ketogenesis and ketolysis 0.7063105996779715 1.6460491392719083 0.0997536425045688 1.0 0.7203647530001598 6 O43772 1 |
| Ferroptosis 0.5406237539516937 1.620625787865724 0.1050979181966025 1.0 0.7203647530001598 27 Q9H1Y0,P09601,Q15043,P04792,P45880,P37268 6 |
| Oxidative stress response 0.6397379849270766 1.6180824272489616 0.1056448350492638 1.0 0.7203647530001598 8 P04179,P09601 2 |
| Metapathway biotransformation phase i and ii 0.5137407957599724 1.6074189076583107 0.1079625051336936 1.0 0.7203647530001598 21 Q99735,Q16850,P07099,P28161,Q9H2H9,O43708,Q7LGA3,P78417,Q9GZZ1,P21964 10 |
| Oxidative phosphorylation 0.5439285428167309 1.5889176312089228 0.112078990079778 1.0 0.7203647530001598 29 P56385,Q86Y39,P51970,O75489,O96000,Q16795,O00483,Q9Y6M9,P24539,O75380,O75306,Q15904,O75964 13 |
| Vitamin d metabolism 0.7654343928868366 1.5830203146089286 0.1134168342437447 1.0 0.7203647530001598 4 P38435,P04062 2 |
| Eicosanoid metabolism via cyclooxygenases cox 0.6904372321562064 1.5754718245262402 0.1151475770332528 1.0 0.7203647530001598 6 Q14914,Q8N8N7 2 |
| Riboflavin and coq disorders 0.6878619262865253 1.5639919388190615 0.1178194615407455 1.0 0.7203647530001598 6 Q16134,Q5T2R2 2 |
| Hippoyap signaling pathway 0.7596391544428703 1.5594476254058314 0.1188904716158494 1.0 0.7203647530001598 4 Q92597,P35240 2 |
| Tryptophan metabolism 0.5320928430729579 1.5300686295646937 0.1259997422470737 1.0 0.7248795112491444 14 P51648 1 |
| Sting pathway in kawasakilike disease and covid19 0.7509078428044137 1.5238786372083468 0.127539030885573 1.0 0.7248795112491444 4 Q86UT6 1 |
| Endothelin pathways 0.5881649501695462 1.5135235681451864 0.1301467192089798 1.0 0.7307320381274829 9 P42892,P00403 2 |
| Electron transport chain oxphos system in mitochondria 0.5879750893780304 1.4713188766240877 0.1412049006912901 1.0 0.7714640030609857 46 P12236,P00403,O75489,O96000,P24539,O75380,P14927,O75964,P14406,Q9UII2,P05141,Q9UDW1,P12235,P56385,P36542,Q16795,P51970,O00483,Q9Y6M9,O75306,P13073 21 |
| Mitochondrial long chain fatty acid betaoxidation 0.5533122738204537 1.4335462499105438 0.1517017915598031 1.0 0.7913937226495976 11 P23786,O43772 2 |
| Mitochondrial complex iv assembly 0.5314335519540216 1.372243595505261 0.1699876180777484 1.0 0.8396224879539129 12 P13073,P14406,Q9Y241 3 |
| Adipogenesis 0.4710695711503597 1.3718196483480731 0.1701195890625575 1.0 0.8396224879539129 19 Q16822,P17096,P10589,P06400,P14174,O00767,P08047,P04150,P43490,O75844 10 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.4932220977247339 1.2889040593099417 0.197431442662308 1.0 0.9084815256340792 14 P17096,P43490,Q13131,O43819,P17174 5 |
| Glycerolipids and glycerophospholipids 0.6431439675642161 1.2720655473231803 0.2033498310568244 1.0 0.9186187541600932 5 Q9HCL2 1 |
| Estrogen receptor pathway 0.6879211289542608 1.266037212251419 0.2054997598767944 1.0 0.9186187541600932 4 Q9HCL2 1 |
| Nad biosynthetic pathways 0.6277966656948536 1.2055237068882996 0.2280011917678095 1.0 0.9492294514414928 5 P43490 1 |
| 1q211 copy number variation syndrome 0.5074958307033886 1.1746721695089068 0.2401258977643654 1.0 0.9595836393407032 11 Q13131 1 |
| S1p receptor signal transduction 0.5488806498887823 1.1622020385483685 0.2451534068130874 1.0 0.9595836393407032 8 P63096,Q13510 2 |
| Onecarbon metabolism and related pathways 0.4837436656195811 1.1574986226868176 0.2470687016922388 1.0 0.9595836393407032 13 P04179,O15382 2 |
| Nonhomologous end joining 0.6533354201186092 1.1244061806238894 0.2608407512440371 1.0 1.0 4 P78527,P12956 2 |
| 7oxoc and 7betahc pathways 0.5102695407669484 1.0968010967644155 0.2727283506613083 1.0 1.0 9 O15118,P61916 2 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.599762393012329 1.0842509069149524 0.2782535658889604 1.0 1.0 5 Q16611,Q9BXK5 2 |
| Hedgehog signaling pathway wp4249 0.5760441714503755 1.0618109205566038 0.2883215311346843 1.0 1.0 6 P17612,P49407 2 |
| Vitamin d receptor pathway 0.4531175479406546 1.040459932626261 0.2981262698236526 1.0 1.0 14 Q92604,P20020,P08183,Q96KA5,P49427 5 |
| Gpr143 in melanocytes and retinal pigment epithelium cells 0.6304875718291394 1.0313434530685133 0.3023797880480821 1.0 1.0 4 P49407,P17612 2 |
| Base excision repair 0.4204199748841015 1.0223821020330337 0.3066000881866499 1.0 1.0 19 Q15054,P78549 2 |
| Mirnas involved in dna damage response 0.5595001252514624 0.911836543371622 0.3618547701708197 1.0 1.0 5 P16104 1 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.4673299798257863 0.905413862058964 0.3652461746917594 1.0 1.0 10 Q92597 1 |
| Oxidative damage response 0.471841531815511 0.8924502073538155 0.3721516702474867 1.0 1.0 9 O95551,O95429,P19838,P12004,Q12933,Q16611 6 |
| Pregnane x receptor pathway 0.5506178989066086 0.8742820856848883 0.3819646527430447 1.0 1.0 5 P12931,P08183 2 |
| Nrf2 pathway 0.4102756530734436 0.8736115471433723 0.3823298356367735 1.0 1.0 22 Q15043,P09601 2 |
| Proteoglycan biosynthesis 0.9084783829309416 0.8659384623817515 0.3865239092755204 1.0 1.0 2 Q8TB61 1 |
| Camkk2 pathway 0.4321759048163974 0.8517261939122701 0.3943660788165259 1.0 1.0 13 P09601 1 |
| Nonalcoholic fatty liver disease 0.5068849132679012 0.8497482555635318 0.3954650635167458 1.0 1.0 51 Q86Y39,P00403,O75489,O96000,Q9NX14,O75380,P14927,P21912,P14406,P54619,Q9UDW1,P08574,Q16795,P51970,Q13131,O00483,Q9Y6M9,O75306,P13073 19 |
| Proteasome degradation 0.4743667335185631 0.824025143255959 0.4099252716760539 1.0 1.0 42 P28074,O75832,P01889,Q06323,P49721,P49720,P61289,P48556,P16104,Q9UNM6,P28070,O43242,P04439,P28072,Q9UL46,O00231,P17980,P60900,P25787,O00233 20 |
| Spinal cord injury 0.3996595409199267 0.8040764041953663 0.4213528508470221 1.0 1.0 22 P06400,P14174,P06493,Q9NQC3,P24941,P11802,P08670 7 |
| Thiamine metabolic pathways 0.5727908361169047 0.8006798788846745 0.4233169939626551 1.0 1.0 4 Q9HC21 1 |
| Nucleotide metabolism 0.3907563821213886 0.7953666004865084 0.426400282456338 1.0 1.0 16 P20839,P11908,P54098,P19623,Q9H2H9,P00374,P31350,P60891 8 |
| Phase i biotransformations non p450 0.880404267265583 0.7752886981539535 0.4381690861433092 1.0 1.0 2 P38571 1 |
| Sulfation biotransformation reaction 0.667686234344842 0.7277084295625157 0.4667920891093011 1.0 1.0 3 O43252 1 |
| Ppar signaling pathway 0.3794302535836454 0.724001287322811 0.4690649447506514 1.0 1.0 16 P23786,O00767 2 |
| Amyotrophic lateral sclerosis als 0.4251552142294574 0.7179311126923235 0.472799762990663 1.0 1.0 11 Q9BUN8,P07197 2 |
| Cannabinoid receptor signaling 0.4744637267500753 0.6980386834183375 0.485153002496131 1.0 1.0 7 Q8NCG7,P17612 2 |
| Disorders of folate metabolism and transport 0.4490082122071522 0.6699787795717419 0.5028713177639448 1.0 1.0 8 P00374 1 |
| Male infertility 0.3815098019915948 0.6645599237176516 0.5063320094243069 1.0 1.0 23 P17096,P54098,P08183,P04179 4 |
| Influence of laminopathies on wnt signaling 0.4475086566240634 0.6629206805471108 0.5073813559818801 1.0 1.0 8 O75844 1 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.4210549383592545 0.660759763555896 0.5087663903624269 1.0 1.0 10 O96013,P35240,P12931 3 |
| Dopamine metabolism 0.6432392834938978 0.6457344403913257 0.5184513521888414 1.0 1.0 3 P17612 1 |
| Cellular proteostasis 0.5289029063455535 0.6330196411737009 0.5267208168360651 1.0 1.0 4 Q9NQP4 1 |
| Fatty acid betaoxidation 0.352822946697838 0.6294035238821687 0.5290849115585021 1.0 1.0 17 O43772 1 |
| Notch1 regulation of endothelial cell calcification 0.8326782706344801 0.6274054658569976 0.5303934857794563 1.0 1.0 2 O43852 1 |
| Lipid metabolism pathway 0.3904208466892484 0.6155619372655525 0.5381836790725141 1.0 1.0 13 P17612,P08559,P54619,Q13131,Q8WTS1,P10644 6 |
| Follicle stimulating hormone fsh signaling pathway 0.3987088499620192 0.548440468472102 0.5833894955302532 1.0 1.0 10 P42345,P17612,Q9UKG1,P49815,P12931,P62753 6 |
| Tp53 network 0.5047603109799823 0.545396451813038 0.5854808802427818 1.0 1.0 4 Q13315 1 |
| Neural crest cell migration during development 0.4019961795356245 0.5382608655173533 0.5903969649394236 1.0 1.0 9 O96013 1 |
| Rala downstream regulated genes 0.4461479005419836 0.5085145024142658 0.6110925712165169 1.0 1.0 6 Q8IYI6,P11233,Q96KP1 3 |
| Interactions between loxl4 and oxidative stress pathway 0.483744750812574 0.4726478068081822 0.6364644690871588 1.0 1.0 4 Q16543 1 |
| Peroxiredoxin 2 induced ovarian failure 0.5873131448326108 0.4700253231081623 0.63833692556168 1.0 1.0 3 P32119 1 |
| Dna mismatch repair 0.3367009177489043 0.4658651044175595 0.6413120604105735 1.0 1.0 20 Q9UQ84 1 |
| P53 transcriptional gene network 0.3757721732660198 0.4391935843075059 0.6605212733934558 1.0 1.0 10 Q9NQ88,Q9H2H9,P04066,P16455,P29590 5 |
| Robo4 and vegf signaling pathways crosstalk 0.576242628475138 0.4376894663363773 0.6616114064361924 1.0 1.0 3 P12931,P63000 2 |
| Myometrial relaxation and contraction pathways 0.3590613121032309 0.3966081467467021 0.6916564440282618 1.0 1.0 30 P17612,P63104,Q9HAV0,P16615,P49407,P05771,P62258,P08047,P10644,P27348,P31946 11 |
| Proximal tubule transport 0.3995262803949737 0.3866310118448431 0.6990293959159426 1.0 1.0 7 P05023,P08183,P05026 3 |
| Ampactivated protein kinase ampk signaling 0.3294216930562979 0.3851235947881398 0.7001458476345523 1.0 1.0 15 P54619,P20248,Q13131,P49815,O00763,Q15717 6 |
| Transcription factor regulation in adipogenesis 0.7419988770353794 0.3781920317528266 0.7052879444025375 1.0 1.0 2 Q16822 1 |
| 15q112 copy number variation syndrome 0.5526335640177897 0.372002305856477 0.7098911325391308 1.0 1.0 3 Q96CW5 1 |
| Neural crest cell migration in cancer 0.3550507550802689 0.3704842651824816 0.7110216983772872 1.0 1.0 11 O96013,O75962,Q99523 3 |
| Cytoplasmic ribosomal proteins 0.4808406267447267 0.3585005509801516 0.7199687556247327 1.0 1.0 77 P61254,P62266,P05387,P35268,P62273,P62249,P62263,P50914,P62753,P46776,P26373,P15880,P39019,P62847,P40429,P47914,P46781,P83881,P46778,P46779,P62910,P46783,P61353,Q9Y3U8,P49207,P62851,P62269,P62854,P23396,P62899,P18621,P62750,P42766,P62841,P62861,P63220,P62244,Q07020,P83731,P62917,P62913,P08708,P62277,P62701,P62906,P51812,P62241,P61927,P61313,P39023,P08865,P62081 52 |
| Congenital generalized lipodystrophy cgl 0.7332959011791192 0.3571353073861443 0.7209905135645942 1.0 1.0 2 P62993 1 |
| Pentose phosphate pathway in senescent cells 0.390778746134387 0.3543586936585874 0.7230700863982953 1.0 1.0 7 P11413,Q9Y315,P49247,P29401,O95336,P37837 6 |
| Onecarbon metabolism 0.3206755739492609 0.3428044385021186 0.7317455866281999 1.0 1.0 15 P00374 1 |
| Modulators of tcr signaling and t cell activation 0.3285658231927194 0.3420579788138306 0.7323072601028573 1.0 1.0 14 P62993,O96000 2 |
| Allograft rejection 0.3418263001359225 0.3387393694527987 0.7348060796544231 1.0 1.0 12 P08183,P04439,P08670,P01889,P19784 5 |
| Neovascularisation processes 0.5394552092108892 0.337453300691601 0.7357752102659652 1.0 1.0 3 P27361,P19838 2 |
| Id signaling pathway 0.7189781021897881 0.323779777909151 0.7461047670851568 1.0 1.0 2 P24941 1 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.3940157262707916 0.3220844076344718 0.747388750309367 1.0 1.0 6 O00584 1 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.3123684448819059 0.3045249652746292 0.7607279757968592 1.0 1.0 15 P20042,O75822,O00303,P55010,O15372 5 |
| Preimplantation embryo 0.3718344975066082 0.2883724411196583 0.7730616609169982 1.0 1.0 7 P17096,P05023 2 |
| Urea cycle and related diseases 0.7001684446940021 0.2825124713227562 0.7775505851652633 1.0 1.0 2 Q9Y619 1 |
| Transsulfuration and onecarbon metabolism 0.2950390154809097 0.273385439565424 0.7845569441751663 1.0 1.0 19 P00374 1 |
| Nipbl role in dna damage cornelia de lange syndrome 0.3784247774918186 0.2732954326148236 0.7846261259906653 1.0 1.0 6 Q13315,P16104 2 |
| Erk pathway in huntingtons disease 0.3871874121944271 0.2718902994745986 0.7857063702654468 1.0 1.0 5 P55210,P28482,P42574,P42858 4 |
| Pparalpha pathway 0.364227023650857 0.2635070227807961 0.7921598113754191 1.0 1.0 7 P23786,P06493 2 |
| Disruption of postsynaptic signaling by cnv 0.3512373453318456 0.2607250606371954 0.7943045387005905 1.0 1.0 8 Q7L576,Q12959,P28482,P27361,P61981,Q13555,Q07157 7 |
| Ccl18 signaling pathway 0.3501286901222751 0.2569009119634262 0.7972552665586132 1.0 1.0 8 Q86UE4,P00403 2 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.3583320461361785 0.2449269907646518 0.8065129624649257 1.0 1.0 7 P42345,Q6R327,P49815 3 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.3009575952899496 0.2254159945417541 0.8216556699671427 1.0 1.0 14 O60725,O75844 2 |
| Relationship between inflammation cox2 and egfr 0.3694224524407219 0.2241967336837774 0.8226042249328898 1.0 1.0 5 P12931,P31751 2 |
| Calcium regulation in cardiac cells 0.3318557481687183 0.2098372276357086 0.8337947163919677 1.0 1.0 35 P27797,P17612,P63104,P63096,Q9HAV0,P16615,P20020,P05026,P61981,P49407,P05771,P62258,P10644,P27348,P29992,P31946,Q04917 17 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3312723000248424 0.2077730237629413 0.8354061968660742 1.0 1.0 35 P17612,P48449,Q16850,Q13131,P53602,O00767,Q9HCL2,Q12770,P37268 9 |
| Homologous recombination 0.3180347429054392 0.2040987935082732 0.8382762971339213 1.0 1.0 10 Q15054 1 |
| Gastric cancer network 2 0.2709581165399731 0.2021584989619584 0.839792816264544 1.0 1.0 17 Q86UE4,Q14739 2 |
| Atm signaling in development and disease 0.3030610059264556 0.1971144224711953 0.8437379973428691 1.0 1.0 27 P78527,Q13131,P06493,P04792,Q13315,Q14739,Q92993,P16104 8 |
| Heme biosynthesis 0.3582466985108244 0.1967692285479386 0.8440081323760245 1.0 1.0 5 P50336,P08397,P36551,P06132 4 |
| Pentose phosphate metabolism 0.3498944963491388 0.1941124769352194 0.8460878122587419 1.0 1.0 6 O95336,P49247,P11413 3 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.2984073087827767 0.1916840242566742 0.8479897207288023 1.0 1.0 13 P42345,P54619,Q13131,P49815,Q05086,P31751,P21359 7 |
| Ciliopathies 0.2817377977099615 0.1914737995285723 0.8481544057188943 1.0 1.0 21 Q15555,Q9UBB4,O75665,Q96EX3,O75695,Q9BYV8,Q10713,Q9BW83 8 |
| Hippo signaling regulation pathways 0.2752279566891673 0.1801124798360519 0.8570642653385607 1.0 1.0 20 P17612,P54619,Q13131,P10644,P35240 5 |
| Aryl hydrocarbon receptor pathway wp2586 0.2934428997005142 0.1747517655975457 0.861274690488117 1.0 1.0 13 P06400,Q16543,P24941,O00170,P12931 5 |
| Small cell lung cancer 0.2616559738245099 0.1679662434194387 0.866609835587377 1.0 1.0 17 P63208,P24941,P31751,P11802,P06756,Q16611 6 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.2964077751631427 0.1651883567910722 0.8687957293055837 1.0 1.0 12 Q32P28,O15460,O75718,Q96AY3 4 |
| Common pathways underlying drug addiction 0.3008827456350234 0.1627588637051989 0.8707082983056975 1.0 1.0 11 P17612,P63096,P62136,P05771,P62140,P36873 6 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.300298800440713 0.1609185269809293 0.8721575700507536 1.0 1.0 11 P37268 1 |
| Complement system 0.3008359874453948 0.1484673902091612 0.8819739195548313 1.0 1.0 10 P17612,P39019,P48729,P26885 4 |
| Prostaglandin and leukotriene metabolism in senescence 0.3616508618996567 0.1475334936785895 0.8827109448382959 1.0 1.0 4 P63096 1 |
| Glial cell differentiation 0.6103312745648634 0.1293088684385077 0.8971132543516325 1.0 1.0 2 P09543 1 |
| Phosphoinositides metabolism 0.2883328105648181 0.1252852148042775 0.9002977568310224 1.0 1.0 11 O95248,Q8TBX8,Q13613 3 |
| Envelope proteins and their potential roles in edmd physiopathology 0.2492006396503774 0.1094751178700189 0.9128256561985044 1.0 1.0 19 O75531,Q14739 2 |
| Chromosomal and microsatellite instability in colorectal cancer 0.2585559013672635 0.1090767222569675 0.9131416376587322 1.0 1.0 22 Q9UJX6,P48729,Q9UHD2,Q96KP1,P11233,Q16611 6 |
| Tca cycle in senescence 0.2987713587225675 0.107850436387898 0.9141143337319666 1.0 1.0 8 P17174,P23368 2 |
| Estrogen signaling pathway 0.2844419958245729 0.0927572616492887 0.9260964048321836 1.0 1.0 9 P17612 1 |
| Constitutive androstane receptor pathway 0.3008406111220621 0.0919416191707737 0.9267444241647912 1.0 1.0 6 P08183 1 |
| Kisspeptinkisspeptin receptor system in the ovary 0.2750266493341958 0.0904025675140859 0.9279673164683206 1.0 1.0 11 P49407,P05771 2 |
| Target of rapamycin tor signaling 0.2665328365681573 0.0824437885290021 0.9342938163327656 1.0 1.0 12 P49815,Q13131 2 |
| Sudden infant death syndrome sids susceptibility pathways 0.2743235308010955 0.0778897760928785 0.9379157321993176 1.0 1.0 32 P17612,P42892,P62258,P67809,P08047,P31946,P12235 7 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.3873135536343906 0.0738908305771105 0.9410972520437462 1.0 1.0 3 Q15758 1 |
| Ovarian infertility 0.3064708261224029 0.0700758749699201 0.94413326847249 1.0 1.0 4 Q13315 1 |
| Alzheimers disease and mirna effects 0.3909987200747134 0.0673069453642189 0.9463373478284608 1.0 1.0 91 Q9UJX6,P12236,P28074,Q14457,P21796,Q9Y277,P45880,Q96IX5,P49721,O95197,P16615,P05141,P07384,P12235,P28070,Q9NQC3,P28072,P60900,P25787,O00233 20 |
| Translation factors 0.2871110206803617 0.0671735672249216 0.9464435278815664 1.0 1.0 39 P60228,Q14232,O75153,P49770,Q9UI10,P20042,O75822,Q14240,O00303,P55010,Q9NR50,O15372,P24534,Q9H074,Q15056 15 |
| Insulin signaling in adipocytes diabetic condition 0.3022116959603423 0.0659000534640304 0.9474573980190856 1.0 1.0 4 P62753,P31751 2 |
| Insulin signaling in adipocytes normal condition 0.3022116959603423 0.0659000534640304 0.9474573980190856 1.0 1.0 4 P62753,P31751 2 |
| Mirna regulation of prostate cancer signaling pathways 0.2775243145830451 0.0635263432932223 0.949347382690228 1.0 1.0 8 Q8NCF5 1 |
| Alzheimers disease 0.3835556618918471 0.0617808596856316 0.9507373461241926 1.0 1.0 90 Q9UJX6,P12236,P28074,Q14457,P21796,Q9Y277,P45880,P49721,O95197,P16615,P05141,P07384,P12235,P28070,Q9NQC3,P28072,P60900,P25787,O00233 19 |
| Purinergic signaling 0.2971910112359465 0.0612809589281908 0.9511354548722092 1.0 1.0 4 P63096,P08754,P09471 3 |
| Quercetin and nfkb ap1 induced apoptosis 0.5404267265581286 0.0608693685400923 0.9514632445589172 1.0 1.0 2 Q14145 1 |
| Pi3kaktmtor vitd3 signaling 0.2759473915607415 0.0569130839386661 0.954614431731645 1.0 1.0 6 P08559,P49815 2 |
| Nuclear receptors metapathway 0.3078167435644716 0.0530058118256395 0.9577272770581636 1.0 1.0 52 Q99735,P09601,P08183,Q15043,P06493,P11802,O00767,Q16543,P28161,O00170,P08047,Q14914,P23786,Q9HCL2 14 |
| Tcell activation sarscov2 0.224915445321311 0.0523039346099844 0.9582865182449744 1.0 1.0 16 Q02750,P42345,P62993,Q8N122,P19838,O95999,P42771,P19174,P28482,P27361,P49815,Q6R327,P04637,O15111,Q9UDY8 15 |
| White fat cell differentiation 0.3557167083383339 0.0507700610253912 0.9595087479393952 1.0 1.0 3 P04150 1 |
| Resistin as a regulator of inflammation 0.2710149001967943 0.0491751569538431 0.960779709186939 1.0 1.0 7 Q16539,P19838,P28482,P27361,P31751,O15111 6 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.2710149001967915 0.0491751569538389 0.9607797091869424 1.0 1.0 7 P28482,P27361,P18206,Q07157,P06756,P12814 6 |
| T cell receptor and costimulatory signaling 0.2707337644082107 0.0487925943486306 0.9610845840004564 1.0 1.0 7 P49840,P19838,P19174,P48729,Q15118,Q08209 6 |
| Osteopontin signaling 0.2639123102866872 0.0437678189124815 0.9650894792788188 1.0 1.0 6 P19838,P28482,P27361,P06756,O15111 5 |
| Angiogenesis 0.2707865168539236 0.041984382101673 0.9665111484164975 1.0 1.0 4 P12931,P28482,Q16539 3 |
| Ciliary landscape 0.2375909660091357 0.0408646539837209 0.9674037959314428 1.0 1.0 111 Q9UPT5,P60660,Q9UBW8,P10619,P08670,P08579,Q15555,P16278,Q8TAG9,Q96KP1,Q9BT78,O15173,P06280,Q9Y266,Q16795,Q9HDC9,Q9NV70,A0AVF1,Q8IVV7,P61019,Q96EX3,Q99627,P07197 23 |
| Dna replication 0.2521907874583073 0.0407959074025248 0.9674586020641552 1.0 1.0 33 P15927,P35244,Q9Y619,P41440,Q9UBD5,Q15054,P24941,O43913,O43929 9 |
| Serotonin receptor 467 and nr3c signaling 0.2637640449438133 0.0381281712003055 0.9695854902660744 1.0 1.0 4 P04150,P28482,P27361 3 |
| Hypertrophy model 0.3296826734063532 0.0380369816031006 0.9696581962964984 1.0 1.0 3 P20248,O75083 2 |
| Angiopoietinlike protein 8 regulatory pathway 0.2471266920391392 0.0353876971274772 0.9717705948386516 1.0 1.0 33 P51812,Q9UPT5,Q13131,P49815,O00767 5 |
| G1 to s cell cycle control 0.2385690814960048 0.0341876681399297 0.9727275001925052 1.0 1.0 30 P15927,P35244,Q9Y619,P06400,P06493,Q9UBD5,Q13315,P24941,O43913,O43929,P11802 11 |
| Nicotine effect on dopaminergic neurons 0.2445916223185243 0.0273026118698229 0.978218373675534 1.0 1.0 6 P17612,P63096 2 |
| Malignant pleural mesothelioma 0.1922316987679835 0.0262806171763885 0.9790335148243512 1.0 1.0 80 Q92597,Q99496,Q14457,Q13315,P06756,P54619,P48729,Q13257,P11802,P12931,Q16611,P51812,Q13131,P49815,P24941,O95816,P08047,P31946,O96013,P35240 20 |
| Wntbetacatenin signaling pathway in leukemia 0.2234364329732072 0.0250910061655836 0.9799823739655776 1.0 1.0 5 P48729 1 |
| Nuclear receptors 0.2627022321694047 0.0230680407094931 0.9815959987184076 1.0 1.0 3 P04150 1 |
| Eicosanoid synthesis 0.4205502526670619 0.0183950778934137 0.9853236790516136 1.0 1.0 2 Q9NP80 1 |
| Dna repair pathways full network 0.2060959231274637 0.0161979271828914 0.9870764891159528 1.0 1.0 58 P78527,P15927,P16455,P12956,Q96T60,Q92889,Q15054,P09429,Q13315,P16104,P29372,P78549,Q9UQ84 13 |
| Nucleotide excision repair 0.2025498309663659 0.016136067984895 0.9871258391651924 1.0 1.0 24 P35244,P41440,Q15054,Q92889,P15927 5 |
| Gpr40 pathway 0.2706344750140527 0.0133991606520323 0.9893093364848278 1.0 1.0 2 P29992 1 |
| Insulin signaling 0.1795219684727447 0.0127579009869774 0.9898209439056996 1.0 1.0 51 Q12846,Q13131,P51812,Q96PE3 4 |
| Endometrial cancer 0.2100788749606448 0.0109130318499193 0.9912928332046796 1.0 1.0 14 Q9UJX6,Q16611,P62993 3 |
| Head and neck squamous cell carcinoma 0.182589386445282 0.0078457988330374 0.9937400224678 1.0 1.0 22 P42771,P06400,Q13131,P49815,Q14145,P31751,P11802,P62753 8 |
| Photodynamic therapyinduced ap1 survival signaling 0.2145957345407518 0.0072161914278211 0.9942423622419672 1.0 1.0 13 P42771,P06400,P20248,Q07820,Q16611 5 |
| Nucleotide excision repair in xeroderma pigmentosum 0.1871951713026258 0.0067609607788975 0.994605574875415 1.0 1.0 33 P35244,P41440,Q15054,Q92889,P15927,Q13098,Q9HCS7 7 |
| Breast cancer pathway 0.177439273083383 0.0049555302951954 0.99604607506982 1.0 1.0 29 Q9UJX6,P63208,P62993,P48729,Q13315,P08047,P31751,P11802,Q16611 9 |
| Pancreatic adenocarcinoma pathway 0.1724137931034505 0.003982602496514 0.996822351356398 1.0 1.0 26 Q13485,P63000,P11233,O15111,P42345,Q16512,P10398,P42224,P31751,Q02750,P40763,Q05655,Q13177,P30086,P11802,Q16611,P61586,P19838,P42771,P06400,P28482,P27361,P60953,O96013,P04637 25 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.2179054054054007 0.0028476308967202 0.9977279223433556 1.0 1.0 12 Q02750,P49840,P19838,Q9NWH9,P28482,Q13485,P27361,P63000,P24941,P31751,P12931 11 |
|
|
